Aspirin for the prevention of cognitive decline in the Elderly: a Neuro-Vascular Imaging Study (ENVIS-ion) from ASPREE [ 2008 - 2015 ]

Also known as: ENVIS-ion Trial

Research Grant

[Cite as]

Researchers: A/Pr Mark Budge (Principal investigator) ,  Prof Walter Abhayaratna (Principal investigator) ,  Prof Andrew Tonkin Prof Christopher Reid Prof David Ames
View all 8 related researchers

Brief description The ENVIS-ion trial will examine whether Aspirin is effective in delaying the onset of worsening of thinking and memory abilities in healthy older adults. Magnetic resonance imaging (MRI) of brain structure will detect markers of early worsening of thinking and memory abilities. Blood vessels in the back of the eye (retina) share many features with vessels in the brain. We will compare whether aspirin lessens changes over time of features shown with brain MRI and retinal photography.

Funding Amount $AUD 1,341,232.62

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]